Publication
Boost delivery in hypofractionated breast cancer radiotherapy: A registry-based analysis of treatment patterns and survival.
Karoline Elisabeth Horry, Dirk Vordermark, Daniel Medenwald, Jörg Andreas Müller
Oncology lettersOct 1, 2026PMID 42643741doi:10.3892/ol.2026.15824 PMC13504658Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 17, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260917-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Hypofractionated radiotherapy (RT) has become standard in breast cancer treatment; however, the factors guiding boost application and its impact on survival remain uncertain. In the present study, predictors of boost application and its association with survival were analyzed. A registry-based…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Breast Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.